160 related articles for article (PubMed ID: 21557538)
1. Design, synthesis, and SAR studies of 4-substituted methoxylbenzoyl-aryl-thiazoles analogues as potent and orally bioavailable anticancer agents.
Lu Y; Li CM; Wang Z; Chen J; Mohler ML; Li W; Dalton JT; Miller DD
J Med Chem; 2011 Jul; 54(13):4678-93. PubMed ID: 21557538
[TBL] [Abstract][Full Text] [Related]
2. Convergent synthesis and biological evaluation of 2-amino-4-(3',4',5'-trimethoxyphenyl)-5-aryl thiazoles as microtubule targeting agents.
Romagnoli R; Baraldi PG; Brancale A; Ricci A; Hamel E; Bortolozzi R; Basso G; Viola G
J Med Chem; 2011 Jul; 54(14):5144-53. PubMed ID: 21663319
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel 2-aryl-4-benzoyl-imidazole (ABI-III) analogues targeting tubulin polymerization as antiproliferative agents.
Chen J; Ahn S; Wang J; Lu Y; Dalton JT; Miller DD; Li W
J Med Chem; 2012 Aug; 55(16):7285-9. PubMed ID: 22783954
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cellular uptake of p-[(123)I]-phenyl-amino-thiazole ((123)I-PAT) as a potential agent for targeting tubulin polymerization in tumors.
Wang DM; Kuo JW; Kuo WT; Hsu CF; Wang MH; Chang Y; Lin WJ; Wang JT
J Labelled Comp Radiopharm; 2014 Mar; 57(3):132-5. PubMed ID: 24408319
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 4-substituted methoxybenzoyl-aryl-thiazole as novel anticancer agents: synthesis, biological evaluation, and structure-activity relationships.
Lu Y; Li CM; Wang Z; Ross CR; Chen J; Dalton JT; Li W; Miller DD
J Med Chem; 2009 Mar; 52(6):1701-11. PubMed ID: 19243174
[TBL] [Abstract][Full Text] [Related]
6. Discovery and optimization of a series of 2-aryl-4-amino-5-(3',4',5'-trimethoxybenzoyl)thiazoles as novel anticancer agents.
Romagnoli R; Baraldi PG; Salvador MK; Preti D; Aghazadeh Tabrizi M; Brancale A; Fu XH; Li J; Zhang SZ; Hamel E; Bortolozzi R; Porcù E; Basso G; Viola G
J Med Chem; 2012 Jun; 55(11):5433-45. PubMed ID: 22578111
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic optimization of 4-substituted methoxybenzoyl-aryl-thiazole and 2-aryl-4-benzoyl-imidazole for improving oral bioavailability.
Li CM; Chen J; Lu Y; Narayanan R; Parke DN; Li W; Ahn S; Miller DD; Dalton JT
Drug Metab Dispos; 2011 Oct; 39(10):1833-9. PubMed ID: 21742898
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel 2-aryl-4-benzoyl-imidazoles targeting the colchicines binding site in tubulin as potential anticancer agents.
Chen J; Wang Z; Li CM; Lu Y; Vaddady PK; Meibohm B; Dalton JT; Miller DD; Li W
J Med Chem; 2010 Oct; 53(20):7414-27. PubMed ID: 20919720
[TBL] [Abstract][Full Text] [Related]
9. Highly potent triazole-based tubulin polymerization inhibitors.
Zhang Q; Peng Y; Wang XI; Keenan SM; Arora S; Welsh WJ
J Med Chem; 2007 Feb; 50(4):749-54. PubMed ID: 17249649
[TBL] [Abstract][Full Text] [Related]
10. Orally bioavailable tubulin antagonists for paclitaxel-refractory cancer.
Li CM; Lu Y; Chen J; Costello TA; Narayanan R; Dalton MN; Snyder LM; Ahn S; Li W; Miller DD; Dalton JT
Pharm Res; 2012 Nov; 29(11):3053-63. PubMed ID: 22760659
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of novel thiazole-naphthalene derivatives as potential anticancer agents and tubulin polymerisation inhibitors.
Wang G; Liu W; Fan M; He M; Li Y; Peng Z
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1694-1702. PubMed ID: 34309466
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity.
Romagnoli R; Baraldi PG; Salvador MK; Preti D; Aghazadeh Tabrizi M; Brancale A; Fu XH; Li J; Zhang SZ; Hamel E; Bortolozzi R; Basso G; Viola G
J Med Chem; 2012 Jan; 55(1):475-88. PubMed ID: 22136312
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and Biological Evaluation of 2-Substituted Benzyl-/Phenylethylamino-4-amino-5-aroylthiazoles as Apoptosis-Inducing Anticancer Agents.
Oliva P; Onnis V; Balboni E; Hamel E; Estévez-Sarmiento F; Quintana J; Estévez F; Brancale A; Ferla S; Manfredini S; Romagnoli R
Molecules; 2020 May; 25(9):. PubMed ID: 32384805
[TBL] [Abstract][Full Text] [Related]
14. New thiazole-2(3H)-thiones containing 4-(3,4,5-trimethoxyphenyl) moiety as anticancer agents.
Ansari M; Shokrzadeh M; Karima S; Rajaei S; Fallah M; Ghassemi-Barghi N; Ghasemian M; Emami S
Eur J Med Chem; 2020 Jan; 185():111784. PubMed ID: 31669850
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and discovery of water-soluble microtubule targeting agents that bind to the colchicine site on tubulin and circumvent Pgp mediated resistance.
Gangjee A; Zhao Y; Lin L; Raghavan S; Roberts EG; Risinger AL; Hamel E; Mooberry SL
J Med Chem; 2010 Nov; 53(22):8116-28. PubMed ID: 20973488
[TBL] [Abstract][Full Text] [Related]
16. (Z)-1-aryl-3-arylamino-2-propen-1-ones, highly active stimulators of tubulin polymerization: synthesis, structure-activity relationship (SAR), tubulin polymerization, and cell growth inhibition studies.
Reddy MV; Akula B; Cosenza SC; Lee CM; Mallireddigari MR; Pallela VR; Subbaiah DR; Udofa A; Reddy EP
J Med Chem; 2012 Jun; 55(11):5174-87. PubMed ID: 22587519
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of imidazo[2,1-b]thiazole linked triazole conjugates: Microtubule-destabilizing agents.
Shaik SP; Nayak VL; Sultana F; Rao AVS; Shaik AB; Babu KS; Kamal A
Eur J Med Chem; 2017 Jan; 126():36-51. PubMed ID: 27744185
[TBL] [Abstract][Full Text] [Related]
18. Drug metabolism and pharmacokinetics of 4-substituted methoxybenzoyl-aryl-thiazoles.
Li CM; Lu Y; Narayanan R; Miller DD; Dalton JT
Drug Metab Dispos; 2010 Nov; 38(11):2032-9. PubMed ID: 20675405
[TBL] [Abstract][Full Text] [Related]
19. Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure.
Dohle W; Jourdan FL; Menchon G; Prota AE; Foster PA; Mannion P; Hamel E; Thomas MP; Kasprzyk PG; Ferrandis E; Steinmetz MO; Leese MP; Potter BVL
J Med Chem; 2018 Feb; 61(3):1031-1044. PubMed ID: 29227648
[TBL] [Abstract][Full Text] [Related]
20. Biological activity of 4-substituted methoxybenzoyl-aryl-thiazole: an active microtubule inhibitor.
Li CM; Wang Z; Lu Y; Ahn S; Narayanan R; Kearbey JD; Parke DN; Li W; Miller DD; Dalton JT
Cancer Res; 2011 Jan; 71(1):216-24. PubMed ID: 21084278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
